2020
DOI: 10.3349/ymj.2020.61.11.923
|View full text |Cite|
|
Sign up to set email alerts
|

LUCAT1 Epigenetically Downregulates the Tumor Suppressor Genes CXXC4 and SFRP2 in Gastric Cancer

Abstract: Purpose The mechanisms of Wnt/β-catenin pathway signaling and abnormal expression of tumor suppressor genes is not well known in gastric cancer (GC). Long non-coding RNA (lncRNA) has recently been identified as a possible link therein. In this study, we investigated the role of lung cancer associated transcript 1 (LUCAT1) in GC. Materials and Methods The expression of LUCAT1 in GC cell lines and 100 tissue samples was examined by qRT-PCR. Two different siRNAs were used … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
3
1
1

Citation Types

0
7
0

Year Published

2021
2021
2024
2024

Publication Types

Select...
5

Relationship

0
5

Authors

Journals

citations
Cited by 6 publications
(7 citation statements)
references
References 39 publications
0
7
0
Order By: Relevance
“…74,75 However, the role of lncRNA JPX in OS has not been reported. In this study, the results showed that melatonin inhibited the expression of The Wnt/β-catenin pathway could regulate multi-tumour development, like lung cancer, 76 intestinal tumour, 77 gastric cancer 78 and glioma. 79 Evidence has proved that Wnt/β-catenin pathway…”
Section: Discussionmentioning
confidence: 73%
See 1 more Smart Citation
“…74,75 However, the role of lncRNA JPX in OS has not been reported. In this study, the results showed that melatonin inhibited the expression of The Wnt/β-catenin pathway could regulate multi-tumour development, like lung cancer, 76 intestinal tumour, 77 gastric cancer 78 and glioma. 79 Evidence has proved that Wnt/β-catenin pathway…”
Section: Discussionmentioning
confidence: 73%
“…The Wnt/β‐catenin pathway could regulate multi‐tumour development, like lung cancer, 76 intestinal tumour, 77 gastric cancer 78 and glioma. 79 Evidence has proved that Wnt/β‐catenin pathway could regulate OS cell behaviours.…”
Section: Discussionmentioning
confidence: 99%
“…Consistently, previous literature has identified CXXC4 as a target of EZH2 and that EZH2 can trigger the activation of the Wnt pathway by downregulating CXXC4, thus accelerating the growth of GC cells [27] . CXXC4 has been validated to express poorly in clinical samples of GC patients and act as a tumor suppressor in GC [ 49 , 50 ]. Strikingly, CXXC4 can disrupt the Wnt/β-catenin pathway activation in breast cancer cells by regulating the phosphorylation of GSK-3β, thus affecting the integrity of the β-catenin degradation complex [51] .…”
Section: Discussionmentioning
confidence: 99%
“…Similarly, it was investigated the functions and molecular mechanisms of LUCAT1 in the carcinogenesis of GC. It was found that LUCAT1 induces methylation of CXXC4 (CXXC finger protein 4), a negative regulator of Wnt/β-catenin signaling and SFRP2, thereby regulating Wnt/β-catenin signaling whose alteration is closely related to the development and progression of GC [ 21 ]. HOTTIP lncRNA, a component of the HomeoboxA cluster in its 5'-end, manipulated multiple processes of cancer like facilitating the proliferation of pancreatic cancer cells [ 101 ], and metastasis of hepatoma [ 102 ].…”
Section: Crosstalk Between Lncrna and Dna Methylation In Cancermentioning
confidence: 99%
“…Obviously, when it comes to gene regulation, tumor occurrence is an inevitable issue that genome-associated studies have showed a huge number of lncRNAs related to diverse types of cancer [ 20 ]. In addition to the abnormal variant in the course of the tumorous initiation and progression, a growing number of researches will be flocked to lncRNAs exceptionally [ 21 , 22 ]. In a word, lncRNA can not only affect gene expression itself but also regulate gene expression and various signaling pathways by interacting with DNA methylation among a lot of cancers, including gastric cancer [ 23 ].…”
Section: Introductionmentioning
confidence: 99%